{"source": "Twitter for iPhone", "reply_settings": "everyone", "id": "1270425500490612738", "context_annotations": [{"domain": {"id": "123", "name": "Ongoing News Story", "description": "Ongoing News Stories like 'Brexit'"}, "entity": {"id": "1220701888179359745", "name": "COVID-19"}}], "lang": "en", "in_reply_to_user_id": "21184460", "conversation_id": "1270306496035926017", "created_at": "2020-06-09T18:40:17.000Z", "possibly_sensitive": false, "referenced_tweets": [{"type": "replied_to", "id": "1270306496035926017"}], "author_id": "1084993633009446914", "text": "@BillHanage Bill, what is your opinion on recent concern that the serology tests we are using are not sensitive enough? Some at @HarvardChanSPH suggested the tests were validated with controls from patients in hospital. Symptomatic and truly mild cases may not develop dectable antibodies", "entities": {"mentions": [{"start": 0, "end": 11, "username": "BillHanage", "id": "21184460"}, {"start": 128, "end": 143, "username": "HarvardChanSPH", "id": "42651647"}]}, "public_metrics": {"retweet_count": 0, "reply_count": 1, "like_count": 0, "quote_count": 0}}